Hamps Bio Ltd. benchmarking: Perfomance to industry peers

Financial

	Hamps Bio	Mono Pharmacare	Chandra Bhagat Pharm
Operational Metrics
Financials
5 yr Average ROE	14.19 %	7.94 %	3.03 %
5yr average Equity Multiplier	2.36	3.7	2.92
5yr Average Asset Turnover Ratio	1.18	1.16	1.46
5yr Avg Net Profit Margin	5.23 %	2.14 %	0.71 %
Price to Book	2.5	1.22	1.0
P/E	73.16	12.29	35.19
5yr Avg Cash Conversion Cycle	74.76 Days	151.42 Days	123.14 Days
Inventory Days	53.3 Days	219.92 Days	97.15 Days
Days Receivable	59.7 Days	79.66 Days	158.67 Days
Days Payable	80.45 Days	54.73 Days	38.34 Days
5yr Average Interest Coverage Ratio	3.45	2.12	1.63
5yr Avg ROCE	18.02 %	11.4 %	10.9 %
5yr Avg Operating Profit Margin	14.19 %	5.11 %	1.16 %
5 yr average Debt to Equity	0.99	2.07	0.76
5yr CAGR Net Profit	20.11 %	34.58 %	35.25 %
5yr Average Return on Assets	6.19 %	2.31 %	1.04 %
Shareholdings
Promoter Holding	71.99 %	56.72 %	72.19 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	0.0	1.77 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Hamps Bio	Mono Pharmacare	Chandra Bhagat Pharm
Product Wise Break-Up	Product Wise Break-Up Freeze Drying Products 50.4 Medicine Products 49.6 0	Product Wise Break-Up 0 Freeze Drying Products 0 Medicine Products 0 Others 100	Product Wise Break-Up API`s 100.0 Freeze Drying Products 0 Medicine Products 0
Product Wise Break-Up	Product Wise Break-Up Freeze Drying Products 50.4 Medicine Products 49.6 0	Product Wise Break-Up 0 Freeze Drying Products 0 Medicine Products 0 Others 100	Product Wise Break-Up API`s 100.0 Freeze Drying Products 0 Medicine Products 0
Location Wise Break-Up	Location Wise Break-Up India 86.58 USA 5.02 UAE 3.2 Canada 2.63 Australia 0.33 Africa 0.17 Europe 0.01 Others 2.06	-	Location Wise Break-Up Australia 0 India 19.75 Europe 0 USA 0 UAE 0 Africa 0 Canada 0 Others 80.25
Operating Profit Break-Up	Operating Profit Break-Up Freeze Drying Products 50.4 Medicine Products 49.6	-	-